Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Raichlen

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Internal Medicine|March 21, 2009
Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR studyM L Bots, M K Palmer, S Dogan, et al.
Journal of the American College of Cardiology|November 1, 1993
Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter TrialL J Crouse, J Cheirif, D E Hanly, et al.
Journal of Internal Medicine|July 6, 2011
Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparisonS A E Peters, H M den Ruijter, M K Palmer, et al.
Journal of the American College of Cardiology|July 21, 1998
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsP A Grayburn, J L Weiss, T C Hack, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Internal Medicine|March 21, 2009
Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR studyM L Bots, M K Palmer, S Dogan, et al.
Journal of the American College of Cardiology|November 1, 1993
Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter TrialL J Crouse, J Cheirif, D E Hanly, et al.
Journal of Internal Medicine|July 6, 2011
Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparisonS A E Peters, H M den Ruijter, M K Palmer, et al.
Journal of the American College of Cardiology|July 21, 1998
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsP A Grayburn, J L Weiss, T C Hack, et al.
Pageof 3